Predicted to enable actin monomer binding activity and calcium ion binding activity. Predicted to be a structural constituent of muscle. Involved in cardiac muscle contraction; cell growth involved in cardiac muscle cell development; and regulation of the force of heart contraction. Located in myofibril. Human ortholog(s) of this gene implicated in familial hypertrophic cardiomyopathy and hypertrophic cardiomyopathy 10. Orthologous to human MYL2 (myosin light chain 2); PARTICIPATES IN E-cadherin signaling pathway; N-cadherin signaling pathway; dilated cardiomyopathy pathway; INTERACTS WITH (R)-adrenaline; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
[Epinephrine co-treated with Xanthine co-treated with XDH] affects the expression of MYL2 protein and [Xanthine co-treated with XDH protein] affects the expression of MYL2 protein
[Epinephrine co-treated with Xanthine co-treated with XDH] affects the expression of MYL2 protein and [Xanthine co-treated with XDH protein] affects the expression of MYL2 protein
Amifostine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MYL2 protein] and Amifostine inhibits the reaction [IL6 protein results in increased phosphorylation of MYL2 protein]
cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [AGT protein results in increased expression of MYL2 protein] and cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of MYL2 mRNA]
Mifepristone inhibits the reaction [[Dexamethasone co-treated with Doxorubicin] results in increased expression of MYL2 mRNA] and Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [[Verapamil co-treated with Doxorubicin] results in decreased expression of MYL2 mRNA]]
[sodium nitrate co-treated with Doxorubicin] results in decreased expression of MYL2 protein and sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of MYL2 protein]
Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] and Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]
Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.
Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
Basal myosin light chain phosphorylation is a determinant of Ca2+ sensitivity of force and activation dependence of the kinetics of myocardial force development.